Cawachi (2664.T) Stock Price

Cawachi Ltd. generates revenue through the sale of pharmaceutical products such as cold medicines, digestive medicines, vitamin tablets, eye drops, and nursing care items. The company also sells cosmetics including basic skin care, makeup, and men's cosmetics, along with miscellaneous goods like detergents, toilet paper, pet items, and milk powders. Food products such as processed foods, dairy, confectioneries, and beverages are sold through its drugstores. The primary customers are retail consumers seeking health, beauty, and household essentials. The business segments include pharmaceuticals, cosmetics, miscellaneous goods, and food products, all distributed via Cawachi's drugstore network. Cawachi Ltd. operates a chain of drugstores that offer a wide range of health and personal care products. The company's product portfolio spans multiple categories, from medicine to daily necessities, targeting both individual shoppers and families. Its drugstores serve as one-stop shops for customers needing everyday items, combining health-focused products with general household goods. The business model relies on high-volume sales of these diverse product lines to drive profitability. The company's revenue streams are derived from direct sales to end consumers through its physical drugstore locations. Cawachi Ltd. does not mention any additional revenue sources such as online sales, subscriptions, or licensing. The focus remains on selling the listed product categories to retail customers in its drugstore network, with no indication of partnerships or third-party services. The business description emphasizes the range of products sold rather than specific customer demographics or pricing strategies.